Posted in | Medical Robotics

First Clinical Procedure Completed using Magellan 10Fr Robotic Catheter

Hansen Medical, Inc., the global leader in intravascular robotics, today announced the completion of the world's first clinical procedure with the Magellan™ 10Fr Robotic Catheter. Interventional radiologist Dr. Gerard Goh performed the procedure at The Alfred Hospital in Melbourne, Australia. Dr. Goh used the 10Fr catheter during a robot-assisted placement of an Inferior Vena Cava (IVC) Filter.

The procedure was supported in partnership with Medtel Pty Limited, Hansen Medical's exclusive distribution partner for the Magellan Robotic System in Australia and New Zealand.

The Magellan 10Fr Robotic Catheter is the latest addition to the family of robotic catheters used with the Magellan Robotic System. The 10Fr catheter allows for independent, robotic control of two telescoping catheters (an outer Guide and an inner Leader catheter). The Guide catheter has a 10Fr outer diameter, and features the largest inner lumen (7Fr) in the Magellan catheter family, which enables delivery of therapeutic devices through the robotic catheter in a broader range of endovascular procedures. The Magellan 10Fr Robotic Catheter received CE Mark approval in April 2015.

"The Magellan 10Fr Robotic Catheter will enable us to expand our use of intravascular robotics in minimally-invasive, endovascular procedures," said Dr. Goh. "The larger, 7Fr inner lumen accommodates many more therapeutic devices, including stents, balloons, and in this case, an IVC filter. The device tracked well through the catheter, and we were able to benefit from the robotic precision and stability that we have experienced during previous therapy delivery with the Magellan 6Fr and 9Fr catheters."

The Magellan Robotic System is an advanced technology that drives Magellan Robotic Catheters and guide wires during minimally-invasive, endovascular procedures. Magellan is designed to offer procedural predictability, precision, and catheter stability as physicians navigate inside blood vessels and deliver therapy. Image-guided medical procedures using interventional fluoroscopy, while growing rapidly, are the leading source of occupational ionizing radiation exposure for medical personnel. Magellan's remote workstation allows physicians to control robotic catheters and guide wires while seated away from the radiation field, which has been shown to reduce radiation exposure for the physician by as much as 95% in complex endovascular procedures2.

"Congratulations to Dr. Goh and the team at The Alfred Hospital on this milestone procedure," said Cary Vance, President and Chief Executive Officer of Hansen Medical. "We are excited that the Magellan 10Fr Robotic Catheter will enable our physician and hospital customers to expand utilization of Magellan. We believe that this will enable more patients to benefit from robotic precision and control in the minimally-invasive treatment of vascular disease."

About the Magellan™ Robotic System

Hansen Medical's Magellan Robotic System is intended to be used to facilitate navigation in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices. The Magellan Robotic System is designed to deliver predictability, control and catheter stability to endovascular procedures. Since its commercial introduction in the U.S. and Europe, the Magellan Robotic System has demonstrated its clinical versatility in many cases in a broad variety of peripheral vascular procedures globally. The Magellan Robotic System offers several important features including:

  • Provides predictability, control and catheter stability as a physician navigates a patient's peripheral vasculature and then provides a conduit for manual treatment of vascular disease with standard therapeutic devices.
  • Is designed to enable more predictable procedure times and increased case throughput potentially allowing hospitals to improve utilization within their vascular business line.
  • Employs an open architecture designed to allow for the subsequent use of many therapeutic devices on the market today.
  • Is designed to potentially reduce physician radiation exposure and fatigue by allowing the physician to navigate procedures while seated comfortably at a remote workstation away from the radiation field and without wearing heavy lead as required in conventional endovascular procedures.
  • The Magellan 9Fr and 10Fr Robotic Catheters allow for independent, robotic control of two telescoping catheters (an outer Guide and an inner Leader catheter), as well as robotic manipulation of standard guide wires.
  • The Magellan 6Fr Robotic Catheter allows for independent robotic control of two separate bend sites on a single catheter, as well as robotic manipulation of standard guide wires. This smaller catheter design may be preferred by certain physicians who prefer a smaller diameter vessel access site, or in procedures in smaller vessels.

Source: http://www.hansenmedical.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hansen Medical. (2019, February 19). First Clinical Procedure Completed using Magellan 10Fr Robotic Catheter. AZoRobotics. Retrieved on August 05, 2020 from https://www.azorobotics.com/News.aspx?newsID=7206.

  • MLA

    Hansen Medical. "First Clinical Procedure Completed using Magellan 10Fr Robotic Catheter". AZoRobotics. 05 August 2020. <https://www.azorobotics.com/News.aspx?newsID=7206>.

  • Chicago

    Hansen Medical. "First Clinical Procedure Completed using Magellan 10Fr Robotic Catheter". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=7206. (accessed August 05, 2020).

  • Harvard

    Hansen Medical. 2019. First Clinical Procedure Completed using Magellan 10Fr Robotic Catheter. AZoRobotics, viewed 05 August 2020, https://www.azorobotics.com/News.aspx?newsID=7206.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit